Results 161 to 170 of about 548,322 (291)

Health technology assessment of an automated unit-dose drug distribution system in a high-specialization national referral hospital of the Italian National Health Service. [PDF]

Glob Reg Health Technol Assess
Croce D, De Nardo F, Convenga F, Mueller D, Franzin M.   +4 more
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Barriers to Home-Based Medication Self-Management Among Older Adults with Multimorbidity: A Qualitative Study Guided by Empowerment Theory

Patient Preference and Adherence
Zhitong Zhang,1 Xiuli Bai,2 Le Hao,3 Yanli Wang2 1School of Nursing, Inner Mongolia Medical University, Hohhot, Inner Mongolia, People’s Republic of China; 2Department of Nursing, Inner Mongolia People’s Hospital, Hohhot, Inner Mongolia, People’s ...
Zhang Z, Bai X, Hao L, Wang Y
doaj  

Improving medication error classification using a reasoning large language model. [PDF]

JAMIA Open
Krifors A, Beskow T, Jonsson M, Lindner KJ, Calås J, Arwsbo V, Sandström K, Norström C.   +7 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

SmUDo (Smart Unit-Dose): Redefining efficiency, quality, and staffing strategies for optimized processes. [PDF]

PLoS One
Gerstmeier J, Herrmann S, Demuth A, Vuong N, Kannt O, Fenske D.   +5 more
europepmc   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

Molecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris, Vasiliki Siozopoulou, Léon C van Kempen, Anne Sieben, Ella Roelant, Stig Hellemans, Elyne Backx, Laure Sorber, Koen De Winne, Senada Koljenović, Karen Zwaenepoel   +10 more
wiley   +1 more source

Exploring consumer and healthcare professional perspectives on discharge medicine communication and solutions for safer transitions of care. [PDF]

BMC Health Serv Res
Oldfield LE, Yong F, Baysari M, Foot H, Manias E, Scott I, Sim TF, Keijzers G, Morgan M, Mullan B, Norman R, Jackson C, Hattingh L.   +12 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Patient safety incidents associated with EMR use: Results of a national survey of Swiss physicians. [PDF]

Digit Health
Schwappach D, Hautz W, Krummrey G, Pfeiffer Y, Ratwani R.   +4 more
europepmc   +1 more source